1. miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1
   Haifeng Zhang et al, 2017, Cancer Chemother Pharmacol CrossRef
2. miR-96 promotes cell proliferation, migration and invasion by targeting PTPN9 in breast cancer.
   Yeting Hong et al, 0 CrossRef
3. MicroRNA-targeted therapeutics for lung cancer treatment
   Jing Xue et al, 2017, Expert Opinion on Drug Discovery CrossRef
4. Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance
   Duncan Ayers et al, 2017, Genes CrossRef
5. miR-96 targets SOX6 and promotes proliferation, migration, and invasion of hepatocellular carcinoma
   Zhengwei Li et al, 2017, Biochem. Cell Biol. CrossRef
6. microRNA-96 acts as a tumor suppressor gene in human osteosarcoma via target regulation of EZRIN
   Qin Yao et al, 2018, Life Sciences CrossRef
7. Exosome RNAs as Biomarkers and Targets for Cancer Therapy
   Akhil Srivastava et al, 2018 CrossRef
8. The reciprocal link between EVI1 and miRNAs in human malignancies
   Wen-Jing Lang et al, 2018, Gene CrossRef
9. miR-96 regulates migration and invasion of bladder cancer through epithelial-mesenchymal transition in response to transforming growth factor-β1.
   Chunfeng He et al, 2018, J Cell Biochem CrossRef
10. Functional validation of miRNAs targeting genes of DNA double-strand break repair to radiosensitize non-small lung cancer cells
    Celeste Piotto et al, 2018, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
11. Effects of AntagomiRs on Different Lung Diseases in Human, Cellular, and Animal Models
    Giuseppe Murdaca et al, 2019, IJMS CrossRef
12. Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J
    Lin Shi et al, 2017, BMC Cancer CrossRef
13. Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans
    Federica Buonocore et al, 2017 CrossRef
14. microRNA-96 regulates the proliferation of nucleus pulposus cells by targeting ARID2/AKT signaling
    Bo Tao et al, 2017 CrossRef
15. Current updates on microRNAs as regulators of chemoresistance
    Metin Çalışkan et al, 2017, Biomedicine & Pharmacotherapy CrossRef
16. Gene expression profile identifies potential biomarkers for human intervertebral disc degeneration
    Wei Guo et al, 2017 CrossRef
17. MicroRNA-96-3p promotes metastasis of papillary thyroid cancer through targeting SDHB
    Xupeng Zhao et al, 2019, Cancer Cell Int CrossRef
18. Verbascoside inhibits progression of glioblastoma cells by promoting Let‐7g‐5p and down‐regulating HMGA2 via Wnt/beta‐catenin signalling blockade
    Wei‐Qiang Jia et al, 2020, J Cell Mol Med CrossRef
19. MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
    Irina Fadejeva et al, 2017, Oncotarget CrossRef
20. miR‑96 promotes collagen deposition in keloids by targeting Smad7
    Li Chao et al, 2018, Exp Ther Med CrossRef
21. Upregulation of miR-96 promotes radioresistance in glioblastoma cells via targeting PDCD4
    Pin Guo et al, 2018, Int J Oncol CrossRef
22. MicroRNA-137-regulated AKT serine/threonine kinase 2 inhibits tumor growth and sensitizes cisplatin in patients with non-small cell lung cancer.
    Zhuming Lu et al, 2018, Oncol Lett CrossRef
23. Hypoxia exposure induced cisplatin resistance partially via activating p53 and hypoxia inducible facor‑1α in non‑small cell lung cancer A549 cells
    Qiang Guo et al, 2018, Oncol Lett CrossRef
24. MicroRNA‑96 expression induced by low‑dose cisplatin or doxorubicin regulates chemosensitivity, cell death and proliferation in gastric cancer SGC7901 cells by targeting FOXO1
    Chunhui Lang et al, 2018, Oncol Lett CrossRef
25. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes
    Sushree S. Sahoo et al, 2020, Best Practice & Research Clinical Haematology CrossRef
26. Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives
    Meenu Mehta et al, 2020, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
27. miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway
    Yi-Nan Liu et al, 2020, Molecular Therapy - Nucleic Acids CrossRef
28. Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy
    Ilaria Guerriero et al, 2020, Pharmaceuticals CrossRef
29. Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators
    Milad Ashrafizadeh et al, 2020, Cellular Signalling CrossRef
30. Kanser hücrelerinde miR-96-5p’nin AIFM3’ü düzenleyerek apoptoz ilişkili sinyali baskılaması
    Esra BOZGEYİK, 2020 CrossRef
31. MicroRNAs and Lung Cancer: A Review Focused on Targeted Genes
    Yao-Hui Wang et al, 2021 CrossRef
32. LncRNAs and miRNAs participate in determination of response of cancer cells to cisplatin
    Mohammad Taheri et al, 2021, Experimental and Molecular Pathology CrossRef
33. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes
    Sushree S. Sahoo et al, 2021, Nat Med CrossRef
34. AIMP3 inhibits cell growth and metastasis of lung adenocarcinoma through activating a miR‐96‐5p‐AIMP3‐p53 axis
    Liting Ding et al, 2021, J Cell Mol Med CrossRef
35. FOXO3a and Its Regulators in Prostate Cancer
    Dominika Ewa Habrowska-Górczyńska et al, 2021, IJMS CrossRef
36. Identification of the Key miRNAs and Genes Associated with the Regulation of Non-Small Cell Lung Cancer: A Network-Based Approach
    Zoya Shafat et al, 2022, Genes CrossRef
37. A perspective to weaponize microRNAs against lung cancer
    Dhanashree Murugan et al, 2022, Non-coding RNA Research CrossRef
38. Extracellular Vesicle (EVs) Associated Non-Coding RNAs in Lung Cancer and Therapeutics
    Anjugam Paramanantham et al, 2022, IJMS CrossRef
39. LIM-domain binding protein 2 was down-regulated by miRNA-96-5p inhibited the proliferation, invasion and metastasis of lung cancer H1299 cells
    Fuying Chu et al, 2023, Clinics CrossRef
40. miR-96 and its versatile role in cancer
    Mohammedazim Bagban et al, 2022, Advances in Cancer Biology - Metastasis CrossRef
41. Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer
    Priya Mondal et al, 2023, Front. Pharmacol. CrossRef
42. The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses
    Giuseppe Ciccone et al, 2023, IJMS CrossRef
43. The miR-183 Cluster: Biogenesis, Functions, and Cell Communication via Exosomes in Cancer
    Shuhui Li et al, 2023, Cells CrossRef
44. MicroRNA-96-5p is negatively regulating GPC3 in the metastasis of papillary thyroid cancer
    Haibei Hu et al, 2023, SAGE Open Medicine CrossRef
45. PARP14 correlates with GBM proliferation and poor prognosis by elevating expression of SAMD/SAMD9L
    Lei Zhang et al, 2024, Ir J Med Sci CrossRef